To prospectively evaluate the safety and feasibility of a diagnostic strategy combining clinical probability, D-dimer testing, (serial) ultrasonography in patients with clinically suspected UEDVT.
ID
Source
Brief title
Condition
- Coagulopathies and bleeding diatheses (excl thrombocytopenic)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary endpoint will be the cumulative 3-month incidence of objectively
confirmed symptomatic venous thromboembolic events including UEDVT and PE in
patients with a normal diagnostic work-up.
Secondary outcome
Not applicable.
Background summary
The reference standard for the diagnosis of upper extremity deep vein
thrombosis (UEDVT) is contrast venography. Unfortunately, venography is
invasive, often difficult to perform and interpret, and it requires the use of
ionizing radiation. The diagnostic work-up of clinically suspected lower
extremity deep vein thrombosis is well established and is based on a combined
strategy involving clinical probability, D-dimer and imaging tests. It remains
unclear whether clinical probability assessment, the D-dimer test,
ultrasonography can be safely used as a diagnostic strategy to detect UEDVT.
Study objective
To prospectively evaluate the safety and feasibility of a diagnostic strategy
combining clinical probability, D-dimer testing, (serial) ultrasonography in
patients with clinically suspected UEDVT.
Study design
A prospective, multicenter, management study. There will be 2 visits; one when
the patient is included and one telephone call after 3 months.
Patients will be categorized as likely or unlikely to have UEDVT based on a
clinical decision rule (CDR). Patients *unlikely* for UEDVT based on the CDR
and with normal D-dimer levels will not receive anticoagulant treatment and
will be followed-up at 3 months. All patients with a likely CDR or unlikely CDR
combined with elevated D-dimer levels will undergo ultrasonography. In case of
a negative or indeterminate ultrasonography result and high D-dimer levels,
serial testing will be repeated 3-5 days later or in case of progressive
complaints. Anticoagulants will be withheld in all patients for whom UEDVT will
be excluded by the initial diagnostic work-up.
Intervention
Not applicable
Study burden and risks
The diagnostic algorithm used in this study has not been validated yet. This
might result in excluding UEDVT in patients while they actually have UEDVT
(i.e. false negative results). However, an algorithm like this has been used
for years in the diagnostical work-up in patients with suspected deep vein
thrombosis of the leg. Moreover, patients are instructed to be aware of
complaints suggestive for UEDVT or pulmonary embolism.
Meibergdreef 9
1100 DD
NL
Meibergdreef 9
1100 DD
NL
Listed location countries
Age
Inclusion criteria
Patients from the emergency department, in and out patient clinic with clinically suspected UEDVT will be eligible for the study.
Exclusion criteria
- No informed consent obtained
- Legal age limitation (country specific)
- Use of anticoagulants in therapeutic dosages longer than 24 hours prior to randomisation
- Prior vein thrombosis in the same arm
- Life expectancy < 3 month
- Haemodynamic instability
- Previous participation in the study
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL29834.018.09 |